Di-PKD: A Pilot Trial of Dietary Intervention in Patients With Autosomal Dominant Polycystic Kidney Disease
Part of paid clinical trials in Loma Linda, California.
- Sponsor
- Loma Linda University
- Study ID
- NCT06786260
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Interventional Diet — OTHERLow salt, limited caffeine, high potassium, low phosphate, and limited protein and carbohydrate intake along with adequate water intake diet
Study Details
The goal of this interventional study is to evaluate the impact of a specific diet (low salt, limited caffeine, high potassium, low phosphate, limited protein, limited carbohydrate intake, adequate water intake) on changes in serum and urinary biomarkers, total kidney volume (TKV), and cyst progression in subjects with autosomal dominant polycystic kidney disease (ADPKD). Researchers will compare the results of subjects in the study diet (interventional) arm to the results of subjects in the regular diet (control) arm.
Key Dates
- Start date
- May 31, 2026
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2026
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Interventional DietSubjects will follow a specified diet (low salt, limited caffeine, high potassium, low phosphate, and limited protein and carbohydrate intake along with adequate water intake) after 1 week of preconditioning for 12 months.
- No Intervention: Regular DietSubjects will follow the diet they normally adhere to after 1 week of preconditioning.
Primary Outcome Measure
Progression of kidney cysts by change in total kidney volume (TKV) from baseline to 12 months [ Time Frame: Change between baseline and 12 months ]
Central Contacts
- Niloufar Ebrahimi Ebrahimi, MD909-558-4000
- Sayna Norouzi, MD909-558-4000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Loma Linda University Health | Loma Linda | California | 92354 | Amir Abdipour, MD 909-202-0252 |
Find similar trials in Loma Linda, CA
Related Studies
- Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)PHASE2 · Recruiting · Vertex Pharmaceuticals Incorporated · Alabaster, Alabama
- Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney DiseaseRecruiting · Richard Fatica · Cleveland, Ohio